Font Size: a A A

The Research And Promotion Strategy Of The Innovation Ability Evaluation System Of The Biomedical Industry

Posted on:2014-07-09Degree:DoctorType:Dissertation
Country:ChinaCandidate:B YangFull Text:PDF
GTID:1360330491453568Subject:Pharmacy Administration
Abstract/Summary:PDF Full Text Request
In recent years,Biotechnology have been developed successfully which become the main driving force in today's international science and technology development.As more and more countries attach importance to the bio-industry,it has become the focus of international competition and an emerging leading industries following the information industry.After that human society entered a new era of bio-economy.In today's society opportunities and challenges exist together and economic globalization is becoming more and more clear.In this situation,China's biomedical industry is facing a critical period when they have to choose the reasonable development strategies to enhance the core competitive ability of the company.In the past years,although a lot of significant and important development of China's biomedical industry had been made,but whether the industrial scale,or in the capacity of independent innovation,there is a big gap when compared with the world's advanced level.Based on China's national conditions,A lot of research is about how to build evaluation system to evaluate the ability of China's Biomedical industry innovation,which is important to shortening the gap between foreign Biomedical industry and ours,this can also enhance China's pharmaceutical industry to gain competitive advantage in the world and a lot of process can be made for China to achieve the biological industry "second five" planning objectives.In order to be understood clearly and easily,eight chapters is divided in this paper.In the first chapter,the background,significance of the topic and what will be intended to study is introduced,at the last of the first part,the main research content,technology roadmap and research methods is outlined;In chapter II,the theory of industrial innovation is introduced briefly,in this part,we discuss how to put forward to innovative view,the concept and connotation and industrial innovation ability of industrial innovation concept is also been discussed;In chapter three,the concept of biotech drugs and Biomedical industry is first defined.the characteristics of the biomedical industry,the situation of foreign pharmaceutical industry development and what china can get from foreign pharmaceutical industry development situation is discussed in the last of this part;In chapter four,we analysis the innovation capability of China's Biomedical industry.In this part,the development situation of China's Biomedical industry,trends and existing problems is included;In chapter five,we build the evaluation system to evaluate the capability of Biomedical industry innovation,and the Likert scale method of analysis and evaluation is described.In chapter six,the value of Biomedical industry is calculated and evaluated using principal component analysis method.In this part,we also analysis the empirical of innovation capability of China's Biomedical industry;In chapter seven,we discuss how to enhance the innovation capability of China's Biomedical industry.a lot of countermeasures is put forward to improve the innovation capability of China's Biomedical industry;In chapter eight,we summary what we have discussed in this paper and outlook the Perspective of the bioengineering and pharmaceutical industry.the creative point and conclusions is also put forward.In the last,we look the directions for future research and content into distance.
Keywords/Search Tags:Biomedical industry, Innovation capability, Likert scale, Empirical study
PDF Full Text Request
Related items